Article Text

Download PDFPDF

PM.90 Incidental Phaeochromocytoma in Pregnancy
  1. BF Chen,
  2. S Al-Samarrai,
  3. M Rathi,
  4. J Rajeswary
  1. King’s Mill Hosptial, Sutton-in-Ashfield, UK


Introduction Phaeochromocytoma, a catecholamine-producing endocrine tumour, is a life-threatening condition to the mother and fetus. The incidence of phaeochromocytoma in pregnancy is extremely rare, 1 in 54 000 pregnancies1. If it remains undiagnosed and untreated, maternal and fetal mortality amounts to 40–50%2 3. Classically, physicians search for the tumour in hypertensive patients with paroxysmal symptoms such as headache, sweating or palpitations. However, our patient presented atypically and would have been left undiagnosed.

Case presentation A 21-year-old presented after a fall at 24 weeks gestation, with loin pain on the contralateral side to the fall. This prompted an ultrasound scan that demonstrated a 9 cm ‘haematoma’ above the right kidney. As she was claustrophobic, she declined magnetic resonance imaging (MRI). A repeat ultrasound was performed which showed the mass to be unchanged. Suspicion arose and an MRI under sedation was performed (as recommended to look for adrenal/renal mass in pregnancy4). This confirmed an 8 cm × 7 cm mass superior to the right kidney. An endocrinologist reviewed her and serum and urine biochemistry investigations were performed.

Her urinary 3-methoxytyramine and serum dopamine levels were raised5 6 indicating possible phaechromocytoma. She did not need α-adrenoceptor blockade, as she remained asymptomatic throughout her pregnancy. She was referred to a tertiary hospital where an elective Caesarean section and surgical tumour removal were performed simultaneously.

Conclusion Diagnosing phaeochromocytoma in an asymptomatic pregnant patient is challenging. However, when diagnosed, a multi-disciplinary team approach (obstetrician, surgeon and endocrinologist) is vital in the management of this rare disorder.


  1. Lenders JWM. Phaeochromocytoma and pregnancy: a deceptive connexion. European Journal of Endocrinology 2012;161:143–150.

  2. Schenker JG & Chowers I. Phaeochromocytoma and pregnancy. Review of 89 cases. Obstetrical and Gynecological Survey 1971;26:739–747.

  3. Dean RE. Phaeochromocytoma and pregnancy. Obstetrics and Gynecology 1958;11: 35–42.

  4. Lenders JW, Eisenhofer G, Mannelli M, et al. Phaeochromocytoma. Lancet 2005;366:665–675.

  5. Peleg D, Munsick RA, Diker D, Goldman JA & Ben-Jonathan N. Distribution of catecholamines between fetal and maternal compartments during human pregnancy with emphasis on L-dopa and dopamine. Journal of Clinical Endocrinology and Metabolism 1986;62:911–914.

  6. Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, Keiser HR, Goldstein DS & Eisenhofer G. Biochemical diagnosis of phaeochromocytoma: which test is best? Journal of the American Medical Association 2002;287: 1427–1434.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.